journal article Aug 01, 2017

EAN consensus review on prevention, diagnosis and management of tick‐borne encephalitis

European Journal of Neurology Vol. 24 No. 10 pp. 1214 · Wiley
View at Publisher Save 10.1111/ene.13356
Abstract
Background and purposeTick‐borne encephalitis (TBE) is an infection of the central nervous system (CNS) caused by tick‐borne encephalitis virus (TBEV) and transmitted by ticks, with a variety of clinical manifestations. The incidence of TBE in Europe is increasing due to an extended season of the infection and the enlargement of endemic areas. Our objectives are to provide recommendations on the prevention, diagnosis and management of TBE, based on evidence or consensus decisions.MethodsFor systematic evaluation, the literature was searched from 1970 to 2015 (including early online publications of 2016), and recommendations were based on evidence or consensus decisions of the Task Force when evidence‐based data were not available.RecommendationsVaccination against TBE is recommended for all age groups above 1 year in highly endemic areas (≥5 cases/100 000/year), but also for individuals at risk in areas with a lower incidence. Travellers to endemic areas should be vaccinated if their visits will include extensive outdoor activities. Post‐exposure prophylaxis after a tick bite is not recommended. A case of TBE is defined by the presence of clinical signs of meningitis, meningoencephalitis or meningoencephalomyelitis with cerebrospinal fluid (CSF) pleocytosis (>5 × 106 cells/l) and the presence of specific TBEV serum immunoglobulin M (IgM) and IgG antibodies, CSF IgM antibodies or TBEV IgG seroconversion. TBEV‐specific polymerase chain reaction in blood is diagnostic in the first viremic phase but it is not sensitive in the second phase of TBE with clinical manifestations of CNS inflammation. Lumbar puncture should be performed in all patients with suspected CNS infection unless there are contraindications. Imaging of the brain and spinal cord has a low sensitivity and a low specificity, but it is useful for differential diagnosis. No effective antiviral or immunomodulating therapy is available for TBE; therefore the treatment is symptomatic. Patients with a potentially life threatening meningoencephalitis or meningoencephalomyelitis should be admitted to an intensive care unit. In the case of brain oedema, analgosedation should be deepened; osmotherapy and corticosteroids are not routinely recommended. If intracranial pressure is increased, therapeutic hypothermia or decompressive craniectomy might be considered. Seizures should be treated as any other symptomatic epileptic seizures.ConclusionsTick‐borne encephalitis is a viral CNS infection that may result in long‐term neurological sequelae. Since its incidence in Europe is increasing due to broadening of endemic areas and prolongation of the tick activity season, the health burden of TBE is enlarging. There is no effective antiviral treatment for TBE, but the disease may be effectively prevented by vaccination.
Topics

No keywords indexed for this article. Browse by subject →

References
263
[17]
Kriz B "Alimentary transmission of tick‐borne encephalitis in the Czech Republic (1997−2008)" Epidemiol Mikrobiol Imunol (2009)
[32]
ProMed‐mail.Tick‐borne encephalitis Germany 2011.http://www.promedmail.org/(accessed 01/04/2015). 10.4172/2157-2526.s1-003
[33]
Institute NPH.http://www3.ktl.fi/stat/(accessed 01/04/2015).
[35]
Paradowska‐Stankiewicz I "Meningitis and encephalitis in Poland in 2013" Przegl Epidemiol (2015)
[38]
Rezza G "Tick‐borne encephalitis in north‐east Italy: a 14‐year retrospective study, January 2000 to December 2013" Euro Surveill (2015)
[39]
Tonteri E "Surveillance of endemic foci of tick‐borne encephalitis in Finland 1995−2013: evidence of emergence of new foci" Euro Surveill (2015)
[41]
The European Commission (EC):Commission Implementing Decision of 8 August 2012 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. Official Journal of the European Union 2012; 55: L262/1‐59.
[42]
The European Centre for Disease Prevention and Control (ECDC).Epidemiological situation of tick‐borne encephalitis in the European Union and European Free Trade Association countries. ECDC Technical Report (2000−2010). Stockholm: ECDC;2012.
[43]
The European Centre for Disease Prevention and Control (ECDC):Second expert consultation on tick‐borne diseases with emphasis on Lyme borreliosis and tick‐borne encephalitis. Meeting Report Stockholm 2012.
[44]
Mohareb E "Tick‐borne encephalitis in Bulgaria, 2009 to 2012" Euro Surveill (2013)
[47]
Schuler M "Epidemiology of tick‐borne encephalitis in Switzerland, 2005 to 2011" Euro Surveill (2014)
[48]
Steffen R "Epidemiology of tick‐borne encephalitis (TBE) in international travellers to Western/Central Europe and conclusions on vaccination recommendations" J Travel Med (2016)
[50]
Bartosik K "Environmental conditioning of incidence of tick‐borne encephalitis in the south‐eastern Poland in 1996−2006" Ann Agric Environ Med (2011)

Showing 50 of 263 references

Cited By
192
Journal of Clinical Medicine
Related

You May Also Like

Alzheimer's disease

C. A. Lane, J. Hardy · 2017

2,250 citations

Multiple sclerosis – a review

R. Dobson, G. Giovannoni · 2018

1,803 citations

Parkinson disease

R. Balestrino, A.H.V. Schapira · 2019

1,336 citations

The economic cost of brain disorders in Europe

J. Olesen, A. Gustavsson · 2011

1,230 citations

Amyotrophic lateral sclerosis: a clinical review

P. Masrori, P. van Damme · 2020

1,038 citations